Oxford Global’s R&D Key 40 Stories 2022

24 October 2022
Download a copy of the R&D Key 40 Stories 2022 ebook today.

We are pleased to share with you selected highlights from Oxford Global’s content portfolios that we have been building over the past few years. In this ebook, a culmination of our efforts, we are delighted to present a variety of the most successful and widely read pieces we have released on our Biologics portal, providing you with invaluable insights into innovative biotherapeutic modalities & developments in biopharmaceutical manufacturing, through to the impact of AI/ML in biologics drug discovery.

Sample (click to enlarge)

To read the ebook in full, please click below to launch our immersive ebook reader

How would you rate this content?

Share this article

Sign up for our monthly Biologics Newsletter

You may also be interested in...

Industry Spotlight
While bispecific antibodies target two specific entities, multispecific antibodies can target more than two. The use of these engineered antibodies offers the potential for enhanced therapeutic strategies by simultaneously addressing multiple aspects of a disease.
16 November 2023
Industry Spotlight
Advancements in cytokine understanding and synthetic immunology enable precise immune modulation, particularly in cancer treatment. However, challenges like short half-lives and side effects impact their wider clinical application.
13 November 2023

Continue browsing

Share this article

Join our Biologics mailing list

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biologics